0001209191-23-041175.txt : 20230705
0001209191-23-041175.hdr.sgml : 20230705
20230705170054
ACCESSION NUMBER: 0001209191-23-041175
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARCIA PETER S
CENTRAL INDEX KEY: 0001188956
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 231070261
MAIL ADDRESS:
STREET 1: ALX ONCOLOGY HOLDINGS INC.
STREET 2: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-30
0
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001188956
GARCIA PETER S
C/O ALX ONCOLOGY HOLDINGS INC.
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-06-30
4
S
0
887
7.34
D
54738
D
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
Includes 1,902 shares acquired under the Issuer's employee stock purchase plan on June 30, 2023.
/s/ Peter Garcia
2023-07-05